news New class of CAR T cells combat previously “untargetable” cancer drivers 4 November 2021 | By Anna Begley (Drug Target Review) The peptide-centric chimeric antigen receptors killed neuroblastoma cells in mice and could potentially expand the pool of immunotherapeutic targets.
news Prenatal editing halts progression of Hurler syndrome in pre-clinical model 14 July 2021 | By Anna Begley (Drug Target Review) US researchers used an AAV9 vector to edit a single base mutation in a prenatal mouse model, halting progression of Hurler syndrome.
news Biomarker for blood vessel damage found in children with SARS-CoV-2 9 December 2020 | By Victoria Rees (Drug Target Review) Elevated levels of a biomarker related to blood vessel damage have been found in all children with SARS-CoV-2 infection.
news Novel targeted treatment shows efficacy in treating high-risk solid tumours 25 August 2020 | By Hannah Balfour (Drug Target Review) The prodrug developed by researchers caused long-term remission in all murine models of high-risk or drug-resistant cancers with fewer side-effects than a comparable drug.
news Algorithm to predict sites of DNA methylation and drug targets developed 7 August 2020 | By Victoria Rees (Drug Target Review) A machine learning algorithm that predicts sites of DNA methylation could aid in the identification of disease-causing mechanisms, say researchers.
news Computational approach identifies novel COVID-19 vaccine targets 9 June 2020 | By Hannah Balfour (Drug Target Review) Researchers used computational tools to identify regions of the SARS-CoV-2 virus that could potentially provide a safe and long-term immune response.
news Myc gene linked to alternative splicing changes in several cancers 18 February 2020 | By Mandy Parrett (Drug Target Review) A collaboration of academic institutions in the United States has identified a gene that is linked to alternative splicing changes that occur in several cancers.
news Schizophrenia gene regulator identified by study 11 September 2019 | By Victoria Rees (Drug Target Review) Using both computational models and stem cell-based experiments, researchers have identified a gene regulator of schizophrenia.
news Rare mechanism for ALL to relapse after CAR-T therapy 2 October 2018 | By Iqra Farooq (Drug Target Review) A single leukemic cell has become resistant to CAR-T therapy after unknowingly engineered with the leukemia-targeting CAR lentivirus...